Key result
A comprehensive review of peripartum cardiomyopathy highlights that despite being a rare and potentially life-threatening disease, timely intervention and early detection can save lives.
Why the study?
Peripartum cardiomyopathy is a potentially life-threatening disease with a rising incidence, where timely intervention and early detection can save lives.
This review provides a comprehensive overview of the epidemiology, pathophysiology, clinical presentation, management, and anesthesia concerns of peripartum cardiomyopathy.
Encourages vigilance for early peripartum cardiomyopathy recognition; leaves open need for prospective trials to guide interventions.
Peripartum cardiomyopathy (PPCM) is a potentially life-threatening disease. However, timely intervention and early detection can save lives. It presents in peripartum period as left ventricular dysfunction and heart failure. Although the disease is relatively rare, its incidence is rising. Previous research states vascular dysfunction, triggered by late-gestational maternal hormones such as abnormal prolactin and many other causes may lead to the development of PPCM. We have reviewed here the known epidemiology, pathophysiology, clinical presentation, management, and anesthesia concerns of PPCM.
No takes yet. Share an insight, caveat, or question.
Kakkar et al. (2020) conducted a review in Peripartum cardiomyopathy. A comprehensive review of peripartum cardiomyopathy highlights that despite being a rare and potentially life-threatening disease, timely intervention and early detection can save lives.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: